We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$3.84B
AUM Growth
+$272M
Cap. Flow
+$189M
Cap. Flow %
4.93%
Top 10 Hldgs %
20.07%
Holding
671
New
230
Increased
99
Reduced
90
Closed
234

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$103M
2
MMM icon
3M
MMM
+$64.5M
3
SNN icon
Smith & Nephew
SNN
+$51.4M
4
MOD icon
Modine Manufacturing
MOD
+$47.9M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$40.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.46%
2 Industrials 14.61%
3 Technology 10.28%
4 Healthcare 8.88%
5 Communication Services 7.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXSM icon
226
Axsome Therapeutics
AXSM
$10.9B
$3.41M 0.09%
40,323
+32,044
+387% +$2.95M
NPKI
227
NPK International
NPKI
$1.12B
$3.4M 0.09%
443,624
+220,026
+98% +$1.62M
M icon
228
CALL
Macy's
M
$6.83B
$3.39M 0.09%
+200,000
New +$3.19M
EL icon
229
CALL
Estee Lauder
EL
$30.6B
$3.37M 0.09%
+45,000
New +$3.55M
BBY icon
230
Best Buy
BBY
$18B
$3.37M 0.09%
+39,230
New +$3.58M
MGTX icon
231
MeiraGTx Holdings
MGTX
$1.1B
$3.35M 0.09%
550,520
-308,759
-36% -$1.81M
VSEC icon
232
VSE Corp
VSEC
$5.82B
$3.31M 0.09%
+34,845
New +$3.67M
TDS icon
233
Telephone and Data Systems
TDS
$3.92B
$3.29M 0.09%
96,473
-547,343
-85% -$16.7M
BRBR icon
234
BellRing Brands
BRBR
$1.51B
$3.28M 0.09%
+43,597
New +$3.1M
TVTX icon
235
Travere Therapeutics
TVTX
$5.11B
$3.16M 0.08%
+181,174
New +$3.2M
FSLY icon
236
Fastly Inc
FSLY
$3.6B
$3.12M 0.08%
+330,782
New +$2.75M
CPAY icon
237
Corpay
CPAY
$25.2B
$3.03M 0.08%
8,947
+697
+8% +$245K
ABNB icon
238
Airbnb
ABNB
$89.4B
$3.01M 0.08%
+22,891
New +$3.08M
IBB icon
239
PUT
iShares Biotechnology ETF
IBB
$9.19B
$3M 0.08%
+22,700
New +$3.19M
STM icon
240
STMicroelectronics
STM
$46.5B
$3M 0.08%
+120,000
New +$3.19M
NVDA icon
241
CALL
NVIDIA
NVDA
$5T
$2.99M 0.08%
+22,300
New +$3.07M
UAL icon
242
United Airlines
UAL
$41.7B
$2.99M 0.08%
30,788
-430,641
-93% -$36.4M
ARDX icon
243
CALL
Ardelyx
ARDX
$1.23B
$2.94M 0.08%
580,700
+310,700
+115% +$1.72M
EWTX icon
244
Edgewise Therapeutics
EWTX
$4.13B
$2.86M 0.07%
107,278
+95,812
+836% +$3.05M
IBB icon
245
CALL
iShares Biotechnology ETF
IBB
$9.19B
$2.79M 0.07%
+21,100
New +$2.97M
CNTA
246
DELISTED
Centessa Pharmaceuticals
CNTA
$2.76M 0.07%
+164,703
New +$2.73M
TRUP icon
247
CALL
Trupanion
TRUP
$1.09B
$2.75M 0.07%
57,000
+600
+1% +$30.8K
GRAB icon
248
Grab
GRAB
$15.1B
$2.7M 0.07%
571,500
-1,263,000
-69% -$5.75M
IBM icon
249
IBM
IBM
$213B
$2.59M 0.07%
11,778
+6,991
+146% +$1.56M
PG icon
250
Procter & Gamble
PG
$338B
$2.58M 0.07%
15,380
-13,342
-46% -$2.27M

Similar funds

J. Goldman & Co's Q4 2024 Portfolio in Review

As of Q4 2024, J. Goldman & Co held 671 positions worth $3.84B, up 7.6% from $3.56B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

J. Goldman & Co deployed $189M of net new capital in Q4 2024, opening 230 new positions and adding to 99 existing holdings. Its largest new stake was 3M: 491,679 shares worth $63.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $67.4M trimmed.

  • J. Goldman & Co's largest Q4 2024 buy was 3M: 491,679 shares worth $63.5M.
  • J. Goldman & Co added most to Walt Disney in Q4 2024, an estimated $103M increase.
  • J. Goldman & Co's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $67.4M.
  • J. Goldman & Co fully exited Comcast in Q4 2024, selling an estimated $79.7M.
  • J. Goldman & Co's ten largest holdings make up 20% of its $3.84B portfolio in Q4 2024.
  • J. Goldman & Co opened 230 new positions and closed 234 in Q4 2024.
  • J. Goldman & Co's portfolio value rose 7.6% quarter-over-quarter to $3.84B.

Based on J. Goldman & Co's 13F filing for Q4 2024, filed 14 Feb 2025.